Matthias Scheffler

Multiple Sclerosis: MicroRNA Expression Profiles Accurately Differentiate Patients with Relapsing-Remitting Disease from Healthy Controls

Andreas Keller, Petra Leidinger, Julia Lange et al. · PLoS ONE · 2009 · 364 citations · Full text

Disease Progression, Immunology, Pathology +16

Toward the blood-borne miRNome of human diseases

Andreas Keller, Petra Leidinger, Andrea S. Bauer et al. · Nature Methods · 2011 · 360 citations

Disease Mechanism, Medicine, Pathogenesis +5

Heterogeneous Mechanisms of Primary and Acquired Resistance to Third-Generation EGFR Inhibitors

Sandra Ortiz‐Cuaran, Matthias Scheffler, Dennis Plenker et al. · Clinical Cancer Research · 2016 · 259 citations · Full text

K-ras Mutation Subtypes in NSCLC and Associated Co-occuring Mutations in Other Oncogenic Pathways

Matthias Scheffler, Michaela A. Ihle, Rebecca Hein et al. · Journal of Thoracic Oncology · 2018 · 247 citations · Full text

Clinical Pharmacokinetics of Tyrosine Kinase Inhibitors

Paola Di Gion, Friederike Kanefendt, Andreas Lindauer et al. · Clinical Pharmacokinetics · 2011 · 214 citations

Medicinal Chemistry, Medicine, Clinical Pharmacokinetics +3